VIKING GLOBAL INVESTORS LP
Institutional investor · Portfolio as of Q4 2021
Top Holdings107 positions
Ginkgo Bioworks Holdings, Inc. | 339.1M | $2.8B | 8.1% | — | — | — | Unchanged 0 |
GE Aerospace | 18M | $1.7B | 4.9% | $62.31 | -7.76% | 2 qtrssince 2021-Q3 | Increased 63 |
T-MOBILE US INC | 13.1M | $1.5B | 4.4% | $109.88 | +0.36% | 8 qtrssince 2020-Q1 | Increased 73 |
HUMANA INC | 2.7M | $1.2B | 3.6% | $388.21 | +15.48% | 3 qtrssince 2021-Q2 | Decreased 0 |
| 17.6M | $1.1B | 3.1% | — | — | 3 qtrssince 2021-Q2 | Increased 61 | |
Microsoft Corp. | 2.9M | $986.3M | 2.8% | $182.94 | +76.76% | 13 qtrssince 2018-Q4 | Decreased 0 |
Parker-Hannifin Corp. | 3.1M | $972.5M | 2.8% | $251.38 | +18.53% | 7 qtrssince 2020-Q2 | Decreased 0 |
Amazon.com, Inc. | 278,199 | $927.6M | 2.7% | $146.92 | +13.48% | 13 qtrssince 2018-Q4 | Increased 71 |
ROIVANT SCIENCES LTD SHS | 88.2M | $889.4M | 2.6% | $10.64 | 0.00% | 1 qtr | New 82 |
Visa Inc | 4M | $860.7M | 2.5% | $208.04 | +0.47% | 13 qtrssince 2018-Q4 | Increased 76 |
API Group Corp | 33.3M | $859M | 2.5% | $8.10 | +112.10% | 7 qtrssince 2020-Q2 | Unchanged 0 |
ADAPTIVE BIOTECHNOLOGIES COR | 30M | $841.6M | 2.4% | $48.30 | -41.35% | 11 qtrssince 2019-Q2 | Unchanged 0 |
Boston Scientific Corporation | 19M | $805.5M | 2.3% | $40.81 | +5.35% | 13 qtrssince 2018-Q4 | Increased 88 |
Twilio Inc | 3M | $784.9M | 2.3% | $265.35 | 0.00% | 1 qtr | New 82 |
COMCAST CORP NEW | 14.2M | $715.3M | 2.1% | $44.48 | -6.73% | 2 qtrssince 2021-Q3 | Increased 72 |
CHUBB LIMITED | 3.7M | $713.7M | 2.1% | $136.16 | +33.85% | 8 qtrssince 2020-Q1 | Increased 65 |
CENTENE CORP DEL | 8.6M | $710.2M | 2.0% | $55.86 | +47.51% | 13 qtrssince 2018-Q4 | Decreased 0 |
COUPA SOFTWARE INC | 4.2M | $658.8M | 1.9% | — | — | 4 qtrssince 2021-Q1 | Increased 53 |
FORTIVE CORP | 8.5M | $647.3M | 1.9% | $45.75 | +23.11% | 10 qtrssince 2019-Q3 | Decreased 0 |
Meta Platforms Inc | 1.9M | $634.5M | 1.8% | $287.30 | +15.96% | 5 qtrssince 2020-Q4 | Increased 55 |
VIKING GLOBAL INVESTORS LP manages $34.7B across 107 positions as of Q4 2021. Top holdings: DNA (8.1%), GE (4.9%), TMUS (4.4%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
Active quarter - 27 new positions, 16 exits, 25 increased. Top move: BSX (INCREASED, conviction 88). Portfolio: $34.7B across 107 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR